318 related articles for article (PubMed ID: 31285289)
1. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens.
Vandeplassche E; Tavernier S; Coenye T; Crabbé A
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285289
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
Caverly LJ; Zhao J; LiPuma JJ
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
[TBL] [Abstract][Full Text] [Related]
4. "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.
Gilligan PH; Downey DG; Elborn JS; Flume PA; Funk S; Gilpin D; Kidd TJ; McCaughan J; Millar BC; Murphy PG; Rendall JC; Tunney MM; Moore JE
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29875191
[TBL] [Abstract][Full Text] [Related]
5. The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects.
Van den Bossche S; De Broe E; Coenye T; Van Braeckel E; Crabbé A
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34526313
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
Conway SP; Brownlee KG; Denton M; Peckham DG
Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
[TBL] [Abstract][Full Text] [Related]
7. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.
Waters VJ; Kidd TJ; Canton R; Ekkelenkamp MB; Johansen HK; LiPuma JJ; Bell SC; Elborn JS; Flume PA; VanDevanter DR; Gilligan P;
Clin Infect Dis; 2019 Oct; 69(10):1812-1816. PubMed ID: 31056660
[TBL] [Abstract][Full Text] [Related]
8. The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.
McCaughey G; Gilpin D; Elborn J; Tunney MM
Expert Rev Respir Med; 2013 Aug; 7(4):385-96. PubMed ID: 23964628
[TBL] [Abstract][Full Text] [Related]
9. Lung function and microbiota diversity in cystic fibrosis.
Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
[TBL] [Abstract][Full Text] [Related]
10.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
11. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
[TBL] [Abstract][Full Text] [Related]
13. Same Game, Different Players: Emerging Pathogens of the CF Lung.
Gannon AD; Darch SE
mBio; 2021 Jan; 12(1):. PubMed ID: 33436426
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
[No Abstract] [Full Text] [Related]
15. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
Tay GT; Reid DW; Bell SC
Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
[TBL] [Abstract][Full Text] [Related]
17. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
18. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
Cribbs SK; Beck JM
Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681
[TBL] [Abstract][Full Text] [Related]
19. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
[TBL] [Abstract][Full Text] [Related]
20. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.
Sibley CD; Parkins MD; Rabin HR; Surette MG
Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]